Our data demonstrated that increased IL-33 expression in gout patients might be a negative feedback mechanism on the MSU-induced inflammation response, because the inflammatory cytokine IL-1β production and the number of neutrophils were both markedly decreased in IL-33-treated mice. This evidence concerns the gene IL1B and gout.